Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Arnold G. Werschky III who wrote (4008)	7/7/1998 8:06:00 PM
From: doormouse	Respond to of 9523

[Lipitor to just about everyone] Your father's office must smell terrible. Lipitor works by efficiently converting cholesterol into dangerous levels of flatulence. <bullish on beano!>

To: Arnold G. Werschky III who wrote (4008)	7/7/1998 8:48:00 PM
From: B.REVERE	Respond to of 9523

Arnold, not sure of the percentage arrangement with WLA on lipitor but heard 35% sometime ago, that could be wrong. Someone on the thread should be able to help, it should have been in their 10-k when the deal was announced last year. The viagra craze will certainly drive pfe to new heights. Predicting a new high after the earnings report next week. Pfizer's next big leap will come when the Fda approves Searle's Celebra. This drug will also set records and Pfiser again has the marketing rites with the deal they cut last quarter. Paid 100 mill to get the rites, but this arthritis drug could easily gross 1/2 billion in the first year. Merck has a competing drug, viiox, that they're trying to get approved by the end of this year. Whoever gets approved first will have a six month advantage, so watch for approvals on both. Good trading, Later, BR